Source positioning close to the tumour in high dose rate (HDR) brachytherapy is not instantaneous. An increment of dose will be delivered during the movement of the source in the trajectory to its static position. This increment is the transit dose, often not taken into account in brachytherapeutic treatment planning. The transit dose depends on the prescribed dose, number of treatment fractions, velocity and activity of the source. Combining all these factors, the transit dose can be 5% higher than the prescribed absorbed dose value
Introduction
Dosimetric methods using solid organic compounds have been developed less than those using inorganic materials. One method using organic material is based on the amino acid alanine and the EPR technique. This technique consists in the detection of unpaired electrons produced by ionizing radiation, without destroying the information in the sample. This dosimetric technique has shown good precision and versatility for high dose rate (HDR) measurements and consequently has been used as a dosimetric method in industrial radiation applications (Van Laere et al 1989 , Miller et al 1989 , Coninckx et al 1989 , Bartolotta et al 1989 , Silveira and Baffa 1995 , McLaughlin and Desrosiers 1995 . Alanine has good signal stability (<0.7% per year), linear response within a broad absorbed dose interval (1-10 5 Gy) Deffner 1982, Alexandre et al 1992) and effective atomic number of 6.79, close to 7.64 for soft tissue. For these reasons, alanine-EPR dosimetry has already been applied in teletherapy (Alexandre et al 1992 , Chu et al 1989 , Schaeken and Scalliet 1996 and in brachytherapeutic research (De Angelis et al 1999) .
In HDR treatment, the total absorbed dose contains a dynamic component during the movement of the source (Sang-Hyun and Muller-Runkel 1994) ; as a consequence the absorbed dose is more than the prescribed one and this difference often is not included in the treatment planning. Failure to account for the transit dose can lead to errors higher than 5% and must be accounted for (Nath et al 1995 , Andreo 1987 . Experimentally, the transit dose for HDR brachytherapy was first determined using a TL dosimeter (Bastin et al 1993) .
The aim of this work is to verify the use of the alanine-EPR dosimetric system in brachytherapy. Also, the radial dose function was measured using the same method and the TG-43 calculation formalism (Nath et al 1995) . The radial dose function defines the nongeometric fall-off of the dose rate for points located in the plane perpendicular to the source axis, normalized to the dose rate at a particular distance r 0 = 1 cm. It depends on absorption and scattering in the tissue, encapsulation and the source material.
The values obtained for the transit dose, as well as for the radial dose function, show that the alanine dosimeter, through EPR analysis, is a viable dosimeter for measurements in brachytherapy.
Materials and methods

Dosimeter preparation
Alanine dosimeters were prepared from a homogeneous mixture of DL-alanine and paraffin (80% and 20% by weight, respectively). The paraffin was passed through a mesh of 0.5 mm and mixed with the alanine. Cylindrical pellets of 4.7 mm diameter and 3 mm height were obtained with nominal mass of 60 mg and volume of 0.052 cm 3 . Each pellet was identified with a graphite mark and was coated with a thin layer of varnish, to prevent humidity absorption from the environment and mass loss during handling. The possible influence of the varnish was tested before (Alexandre et al 1992) and no significant contribution to the signal was found in the dose range used in this work.
EPR spectrum acquisition
The EPR spectrum first derivative or first harmonic (1h) from the irradiated alanine dosimeters was recorded in a VARIAN E-4 spectrometer operating in X-Band (ν ≈ 9.5 GHz) and TE 102 mode. Some spectrometric parameters were selected to optimize the spectrum in order to obtain the highest possible amplitude. The microwave power and modulation amplitude used were 50 mW and 1 mT, respectively. With this modulation amplitude value, the signal was overmodulated. Other parameters were 325 mT central magnetic field, 20 mT scanning field and 2 min scanning time. A complete experimental set-up description and the signal evaluation method are mentioned elsewhere (Chen et al 2002) .
Dosimeter irradiation
The alanine pellets were irradiated (figure 1) with gamma rays from the 35.52 × 10 10 Bq 192 Ir source in the HDR Nucletron, microSelectron Classic. We also use a Siemens/Mevatron 74 10-MeV electron linear accelerator. The linac dose was measured with an ionization chamber calibrated to a secondary standard following the IAEA TRS-277 method (Andreo 1987). All the irradiations were made with electronic equilibrium conditions. We estimate a maximum uncertainty of 1 mm in positioning the dosimeters. Dosimeters in another configuration were irradiated with 10 MeV x-ray photons. In a 2 cm thick PMMA plate four alanine dosimeters were inserted in four holes and were covered with a PMMA plate of 2.5 cm thickness to obtain build-up. This configuration was irradiated at a source-surface distance (DSS) of 100 cm, field size of 5 × 5 cm 2 and doses of 5-15 Gy, four dosimeters per dose value.
Transit dose determination.
The transit dose absorbed by the tumour and the surrounding tissues depends linearly on the strength of the radioactive source, on the number of times n that the source enters and exits its static position and on its velocity along the trajectory. Figure 3 shows device II that can hold ten pairs of alanine dosimeters symmetrically positioned with 1 cm intervals between them and 5 mm distant from the centre of the trajectory for entry to and exit from the static position. To simulate soft tissue, this device was manufactured of acrylic.
For a single round trip journey of the source, a given dosimeter pair measured a dose D 1x that is the sum of the transit dose D tx and the static dose D sx , where x is an index which specifies the position of one dosimeter pair relative to the static position of the source. The static dose depends on the time t that the source remains in position. A second dose observation, D 2x , is made after n round trip journeys in which the source delivers the same static dose as in the first experiment, but the transit dose will be n times greater. The transit dose at each of the ten positions is then related to the difference of the two observations:
Twenty dosimeters were placed along the interstitial needle of device II and the HDR equipment was programmed such that the 192 Ir source could irradiate a selected point at the end of the trajectory for 0.1 s for 170 times. The static dose D sx was identical to that accumulated in another experiment: twenty dosimeters were irradiated by the 192 Ir source in the same configuration as before for only one time for 17 s. From these two observations the experimental transit dose D tx was determined from equation (1).
Radial dose function determination.
Alanine dosimeters were placed in the acrylic dosimeter holders (A, B, C and D in figure 1) that were placed at a given distance from the source during irradiation. In this way, an average of four measurements was obtained for each distance r and angle θ . Separate alanine dosimeters were irradiated in water at distances of 1.00, 1.50, 2.00, 2.50, 3.00, 3.50, 5.50 and 7.50 cm from the 192 Ir source and the radial dose function g(r) was measured using the experimental dose D(r, θ) and the TG-43 protocol (Nath et al 1995) with the equation:
where D(r 0 , θ 0 ) is the experimental dose at r 0 = 1 cm and θ 0 = π/2.
Source velocity determination
We evaluated the transit dose for a specific radioactive source positioned by a computercontrolled device, whose velocity characteristics were experimentally determined. A measurement of the source velocity along its trajectory to the static position was determined to evaluate how it influences the transit dose value, together with the number of treatment fractions and source activity. The source velocity was obtained using a lead plate with two holes separated by 15 mm. In the holes, two diode sensors were positioned to measure the source passage times. These sensors were aligned with the source trajectory and the time elapsed between the two diode signals was detected by an oscilloscope. The sensor assembly could be displaced along the trajectory of the source. Average velocity values and their uncertainties were determined for each point along the trajectory to the static position.
Results
Calibration
The calibration curves, obtained with the 192 Ir source and 10 MeV x-rays, agree within experimental errors, confirming that the alanine dosimeter does not have significant energy dependence (Bergstrand et al 2003) . The small difference between the two linear coefficients is due to slightly differing calibration conditions. The 192 Ir γ rays irradiated the alanine dosimeters laterally at small distances where there exists a strong dose gradient across the dosimeter volumes. The 10 MV photons irradiated the pellets at a much larger SSD where there is a homogeneous dose in the dosimeters.
In the geometries used for determination of the transit dose and the radial dose functions, no high dose gradients were encountered.
192 Ir source velocity and transit dose
From the measurements of the velocity along the source trajectory, figure 4(a) shows differences occurring in the last ten centimetres in the trajectory. One can see in figure 4(b) the velocity behaviour in the last ten centimetres of interest for the transit dose analysis. The transit dose in figure 5 was obtained using the difference between multiple and single HDR dosimeter exposures. The transit dose is presented at ten dosimeter positions, along the source trajectory. One can observe that the transit dose increases as the source reaches the end of its trajectory, owing to the deceleration of the source as shown in figure 4(b) . In the literature (Bastin et al 1993) , the transit dose was obtained with TLD dosimeters for a point corresponding to 8 cm source-dosimeter distance. Our experimental transit dose at that distance is compared with the TLD value in table 1. From the results, one can see that the values obtained are 3 and 6% lower than the TLD value (Bastin et al 1993) and our transit dose from the 192 Ir calibration curve is higher than that from the linac calibration curve.
The transit dose must be taken into account in patient brachytherapy planning. For example, at a point 5 mm equidistant from four needles inserted in a target volume, with a source of 3.7 × 10 10 Bq, using 12 irradiation fractions of 300 cGy each, the transit dose would be 5% of the total prescribed dose at this point. This is not an unusual situation. To attain 1% precision for the prescribed dose to the tumour, the transit dose contribution in this example must be known to better than 20% precision. Thus, all our results are sufficiently precise to evaluate the contributions of the transit dose to the prescribed one.
Radial dose function
Exposures were made in seven positions in device I and at eight source-dosimeter distances. Figure 6 presents the EPR amplitude versus source to dosimeter distance in water. From this figure, one can see that the EPR amplitude decreases geometrically and by attenuation in water. The dosimeters that are placed symmetrically above and below the central dosimeter number 4 are at the same distance from the centre of the source and will have practically the same radial dependence (figure 1).
With the data from figure 6 and using equation (2), the points for radial dose function behaviour were calculated. Figure 7 shows the radial dose function values together with those from different authors. The results obtained here are in accordance with other published values for distances smaller than 5 cm, but for larger distances, the alanine dosimeters values agree better with the values obtained with Monte Carlo simulations (Williamson et al 1991 , Ballester et al 1997 , 2001 ). For distances less than 1 cm, we could not obtain the g(r) function, because the alanine dosimeter size did not provide adequate spatial resolution relative to the 192 Ir dose gradient. 
Conclusions
The static dose D sx may be planned in the conventional way by the medical physicist, and the transit dose D tx must be considered and, when significant, added to the static dose. The transit dose values, obtained for the first time using a first harmonic alanine-EPR dosimeter, are close to those reported in the literature using TLD. The radial dose function, obtained from alanine EPR measurements, agrees with Monte Carlo simulations. The agreement with TLD values is satisfactory only for distances less than 5 cm.
We conclude that the alanine-EPR dosimeter can be useful for HDR brachytherapeutic dosimetry. Smaller alanine dosimeters could be used for higher spatial resolution.
